NCBiotech News
We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.
August 11, 2020
A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell therapy startups with plans to build an $83 million biomanufacturing facility in Durham that could employ more than 200 people over five years.
August 4, 2020
The Dole Food Company has entered a five-year strategic partnership with the young RTP-based ag tech company Elo Life Systems to keep bananas alive and available, because Elo's gene editing technology is uniquely qualified to develop Fusarium-resistant banana varieties.
August 3, 2020
North Carolina’s economic development efforts are recognized in Business Facilities magazine’s 2020 Metro Rankings Report, with the City of Raleigh number one on its list of GDP leaders in mid-size metro markets.
August 3, 2020
The North Carolina Biotechnology Center awarded 34 grants and loans totaling nearly $2 million to universities, biosciences companies and other entities in the fourth quarter of its last fiscal year.
July 31, 2020
Grifols, a global biotherapeutics company with major operations in North Carolina, has delivered the first batches of a therapeutic product manufactured in Clayton that could help prevent and treat COVID-19 infection.
July 31, 2020
North Carolina’s strength in the life sciences and its strong business climate have landed it, again, among the nation’s best on Business Facilities Magazine's 16th Annual Rankings Report for 2020.
July 30, 2020
A British startup which opened U.S. headquarters in Raleigh earlier this year, Verona Pharma, has landed a $200 million “oversubscribed” private placement of stock.
July 30, 2020
Greensboro diagnostics and drug screening company Carolina Liquid Chemistries (CLC) is now selling COVID-19 test kits.
July 28, 2020
Raleigh pharmaceutical upstart 9 Meters Biopharma has secured patent protection for its potential gastrointestinal drug for additional use in treating lung disease.
July 28, 2020
RTP oncology company G1 Therapeutics has out-licensed a potential drug for treating certain breast and lung cancers to a Massachusetts startup in a deal that could be worth more than $300 million.
July 28, 2020
RTP-based contract research giant IQVIA has launched a program that waives licensing and access fees for approved academic researchers as part of its efforts to accelerate research on how COVID-19 is impacting the healthcare industry and related treatment.
July 28, 2020
The NCBiotech-supported Summer Undergraduate Research Program at Western Carolina University has adapted well to the world of digital communication.
July 28, 2020
Winston-Salem's EncepHeal Therapeutics has landed a federal grant to support development of its novel medications for cocaine addiction.
July 27, 2020
Less than two years after launching, Avior Bio is kicking off its first human trial for a novel drug therapy treating pruritus, or chronic itchy skin
July 27, 2020
RTP-based Panaceutics Nutrition has launched I-Vive, a new line of single-serve nutritional products compounded for the general public